Dr. Jody Dushay shares her observation that patients prescribed Ozempic or similar off-label drugs for weight management are no longer able to get insurance coverage for those drugs. Making these medications unavailable robs the patients of optimal medicine and care, she argues.

Related Keywords

Boston , Massachusetts , United States , Jody Dushay , Beth Israel Deaconess Medical Center , Cnn , Assistant Professor , Harvard Medical School , Type 2 Diabetes , Medicare Patients , Body Weight , Weight Management , Weight Loss , Blood Pressure , Diabetes , Powerful Tools ,